Primary Uses
1. Management of Hypocalcemia
- Purpose: Used to treat hypocalcemia (low levels of calcium in the blood) in patients undergoing chronic renal dialysis. Calcitriol helps increase calcium absorption from the gut and reduces calcium loss through the kidneys, helping to maintain adequate blood calcium levels.
2. Secondary Hyperparathyroidism
- Purpose: Used to manage secondary hyperparathyroidism in patients with chronic renal failure. It helps to regulate parathyroid hormone (PTH) levels, which can become elevated due to low calcium levels, leading to bone disease and other complications.
3. Hypoparathyroidism
- Purpose: Used to manage hypocalcemia in patients with hypoparathyroidism, a condition where the parathyroid glands do not produce sufficient amounts of PTH, leading to low calcium levels.
Mechanism of Action
Calcitriol is the active form of vitamin D3 and works by promoting the absorption of calcium and phosphorus from the gut. It also helps regulate the levels of calcium and phosphate in the blood and bone, enhancing bone mineralization and overall calcium homeostasis.
Administration
- Intravenous Injection: Administered intravenously, typically during dialysis sessions for patients with chronic renal failure. The dose and frequency depend on the patient's condition, calcium levels, and response to treatment.
Side Effects
- Common: Hypercalcemia (high levels of calcium in the blood), nausea, vomiting, and weakness.
- Serious: Hypercalciuria (high levels of calcium in the urine), hyperphosphatemia (high levels of phosphate in the blood), kidney stones, and soft tissue calcification.
Precautions
- Monitoring: Regular monitoring of serum calcium, phosphate, and PTH levels is essential to avoid complications like hypercalcemia and hyperphosphatemia.
- Kidney Function: Use with caution in patients with compromised kidney function, as calcitriol can affect calcium and phosphate balance.
- Vitamin D Toxicity: Be aware of the signs and symptoms of vitamin D toxicity, such as weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain, and metallic taste.
Interactions
- Calcium Supplements and Antacids: Concurrent use with calcium supplements or antacids containing calcium can increase the risk of hypercalcemia.
- Thiazide Diuretics: Thiazide diuretics can increase the risk of hypercalcemia when used with calcitriol.
- Phosphate Binders: May be necessary to use phosphate binders to manage serum phosphate levels when administering calcitriol.
Conclusion
Calcitriol Injection is an important medication for managing conditions related to calcium and phosphate metabolism, particularly in patients with chronic renal failure and those undergoing dialysis. Its use requires careful monitoring and dose adjustment to maintain balanced calcium and phosphate levels and prevent complications.
Block/Survey No. 497, Mauhuvej, nr. Fairdeal Textile Park, Kosamba, Gujarat 394125, India